GLYSET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glyset, and what generic alternatives are available?
Glyset is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in GLYSET is miglitol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the miglitol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glyset
A generic version of GLYSET was approved as miglitol by WESTMINSTER PHARMS on February 24th, 2015.
Summary for GLYSET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Patent Applications: | 5,018 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for GLYSET |
What excipients (inactive ingredients) are in GLYSET? | GLYSET excipients list |
DailyMed Link: | GLYSET at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for GLYSET
US Patents and Regulatory Information for GLYSET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-001 | Dec 18, 1996 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-002 | Dec 18, 1996 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-003 | Dec 18, 1996 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GLYSET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-001 | Dec 18, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-002 | Dec 18, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | GLYSET | miglitol | TABLET;ORAL | 020682-003 | Dec 18, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for GLYSET
See the table below for patents covering GLYSET around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 285084 | ⤷ Try a Trial | |
Japan | S6231703 | ⤷ Try a Trial | |
Denmark | 377678 | ⤷ Try a Trial | |
Denmark | 152123 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for GLYSET
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0266730 | 98C0014 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MIGLITOL; NAT. REGISTRATION NO/DATE: NL 22 138 19970204; FIRST REGISTRATION: NL - 19 343 UR 19960723 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |